nodes	percent_of_prediction	percent_of_DWPC	metapath
Paramethadione—CYP2C9—Estropipate—osteoporosis	0.117	0.12	CbGbCtD
Paramethadione—CYP2C8—Raloxifene—osteoporosis	0.112	0.115	CbGbCtD
Paramethadione—CYP2C8—Ethinyl Estradiol—osteoporosis	0.108	0.111	CbGbCtD
Paramethadione—CYP2C8—Cholecalciferol—osteoporosis	0.0867	0.0884	CbGbCtD
Paramethadione—CYP2C8—Estradiol—osteoporosis	0.0699	0.0713	CbGbCtD
Paramethadione—CYP3A4—Estropipate—osteoporosis	0.0683	0.0696	CbGbCtD
Paramethadione—CYP3A4—Calcitriol—osteoporosis	0.0683	0.0696	CbGbCtD
Paramethadione—CYP2C9—Cholecalciferol—osteoporosis	0.0605	0.0617	CbGbCtD
Paramethadione—CYP3A4—Ergocalciferol—osteoporosis	0.0546	0.0557	CbGbCtD
Paramethadione—CYP2C9—Estradiol—osteoporosis	0.0488	0.0497	CbGbCtD
Paramethadione—CYP3A4—Raloxifene—osteoporosis	0.0456	0.0465	CbGbCtD
Paramethadione—CYP3A4—Ethinyl Estradiol—osteoporosis	0.044	0.0449	CbGbCtD
Paramethadione—CYP3A4—Cholecalciferol—osteoporosis	0.0352	0.0359	CbGbCtD
Paramethadione—CYP3A4—Conjugated Estrogens—osteoporosis	0.0323	0.0329	CbGbCtD
Paramethadione—CYP3A4—Estradiol—osteoporosis	0.0284	0.0289	CbGbCtD
Paramethadione—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.000981	0.0507	CbGpPWpGaD
Paramethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—DKK1—osteoporosis	0.000645	0.0333	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—CAP1—osteoporosis	0.000572	0.0296	CbGpPWpGaD
Paramethadione—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—osteoporosis	0.000483	0.025	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—CAP1—osteoporosis	0.000421	0.0218	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—CAP1—osteoporosis	0.000408	0.0211	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—CAP1—osteoporosis	0.000408	0.0211	CbGpPWpGaD
Paramethadione—CACNA1I—NCAM signaling for neurite out-growth—IL6R—osteoporosis	0.00039	0.0202	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—TLN1—osteoporosis	0.000358	0.0185	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—ACTG1—osteoporosis	0.000353	0.0183	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—CAP1—osteoporosis	0.000301	0.0156	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—CAP1—osteoporosis	0.000291	0.0151	CbGpPWpGaD
Paramethadione—CACNA1G—NCAM signaling for neurite out-growth—IL6R—osteoporosis	0.000287	0.0149	CbGpPWpGaD
Paramethadione—CACNA1H—NCAM signaling for neurite out-growth—IL6R—osteoporosis	0.000278	0.0144	CbGpPWpGaD
Paramethadione—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000268	0.0139	CbGpPWpGaD
Paramethadione—CYP2E1—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000265	0.0137	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—TLN1—osteoporosis	0.000264	0.0136	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—ACTG1—osteoporosis	0.00026	0.0135	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—TLN1—osteoporosis	0.000256	0.0132	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—TLN1—osteoporosis	0.000255	0.0132	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—ACTG1—osteoporosis	0.000252	0.013	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—ACTG1—osteoporosis	0.000252	0.013	CbGpPWpGaD
Paramethadione—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000232	0.012	CbGpPWpGaD
Paramethadione—CYP2C8—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000229	0.0118	CbGpPWpGaD
Paramethadione—CACNA1H—Corticotropin-releasing hormone—POMC—osteoporosis	0.000224	0.0116	CbGpPWpGaD
Paramethadione—CYP2E1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000217	0.0112	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—WNT1—osteoporosis	0.000196	0.0102	CbGpPWpGaD
Paramethadione—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000194	0.01	CbGpPWpGaD
Paramethadione—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000189	0.00976	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—TLN1—osteoporosis	0.000188	0.00974	CbGpPWpGaD
Paramethadione—CYP2C8—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000188	0.00972	CbGpPWpGaD
Paramethadione—CYP2C9—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000186	0.00963	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—ACTG1—osteoporosis	0.000186	0.00961	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—TLN1—osteoporosis	0.000182	0.00943	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—ACTG1—osteoporosis	0.00018	0.00931	CbGpPWpGaD
Paramethadione—CYP2E1—Tryptophan metabolism—CYP19A1—osteoporosis	0.000174	0.00901	CbGpPWpGaD
Paramethadione—CACNA1I—NCAM signaling for neurite out-growth—IL6—osteoporosis	0.000174	0.00898	CbGpPWpGaD
Paramethadione—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000157	0.00811	CbGpPWpGaD
Paramethadione—CYP2C9—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000153	0.00791	CbGpPWpGaD
Paramethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—osteoporosis	0.00015	0.00773	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—WNT1—osteoporosis	0.000145	0.00749	CbGpPWpGaD
Paramethadione—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000141	0.00729	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—WNT1—osteoporosis	0.00014	0.00725	CbGpPWpGaD
Paramethadione—CYP2E1—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000139	0.00719	CbGpPWpGaD
Paramethadione—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000136	0.00706	CbGpPWpGaD
Paramethadione—CACNA1H—Corticotropin-releasing hormone—TGFB1—osteoporosis	0.000129	0.00668	CbGpPWpGaD
Paramethadione—CACNA1G—NCAM signaling for neurite out-growth—IL6—osteoporosis	0.000128	0.00662	CbGpPWpGaD
Paramethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000124	0.00644	CbGpPWpGaD
Paramethadione—CACNA1H—NCAM signaling for neurite out-growth—IL6—osteoporosis	0.000124	0.00641	CbGpPWpGaD
Paramethadione—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000123	0.00635	CbGpPWpGaD
Paramethadione—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000122	0.0063	CbGpPWpGaD
Paramethadione—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.00012	0.00622	CbGpPWpGaD
Paramethadione—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000117	0.00606	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—CYP27A1—osteoporosis	0.000116	0.00597	CbGpPWpGaD
Paramethadione—CYP2C8—Arachidonic acid metabolism—GPX1—osteoporosis	0.000115	0.00593	CbGpPWpGaD
Paramethadione—CYP2E1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000114	0.00591	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—CYP27A1—osteoporosis	0.000114	0.00589	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—IL6R—osteoporosis	0.000112	0.00578	CbGpPWpGaD
Paramethadione—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000101	0.00522	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—CYP27A1—osteoporosis	9.99e-05	0.00516	CbGpPWpGaD
Paramethadione—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	9.91e-05	0.00513	CbGpPWpGaD
Paramethadione—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	9.87e-05	0.00511	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—CYP27A1—osteoporosis	9.85e-05	0.00509	CbGpPWpGaD
Paramethadione—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	9.78e-05	0.00506	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—LEP—osteoporosis	9.52e-05	0.00492	CbGpPWpGaD
Paramethadione—CYP2C9—Arachidonic acid metabolism—GPX1—osteoporosis	9.34e-05	0.00483	CbGpPWpGaD
Paramethadione—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	9e-05	0.00466	CbGpPWpGaD
Paramethadione—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	8.47e-05	0.00438	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—IL6R—osteoporosis	8.24e-05	0.00426	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—CYP27A1—osteoporosis	8.13e-05	0.0042	CbGpPWpGaD
Paramethadione—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	8.09e-05	0.00418	CbGpPWpGaD
Paramethadione—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	8.04e-05	0.00416	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—CYP27A1—osteoporosis	8.02e-05	0.00414	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—IL6R—osteoporosis	7.98e-05	0.00413	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—IL6R—osteoporosis	7.98e-05	0.00413	CbGpPWpGaD
Paramethadione—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	7.32e-05	0.00379	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—LEP—osteoporosis	7.02e-05	0.00363	CbGpPWpGaD
Paramethadione—CYP2E1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	6.87e-05	0.00355	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—LEP—osteoporosis	6.8e-05	0.00352	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	6.68e-05	0.00345	CbGpPWpGaD
Paramethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	6.54e-05	0.00338	CbGpPWpGaD
Paramethadione—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	6.45e-05	0.00334	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	6.33e-05	0.00327	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—CYP19A1—osteoporosis	6.07e-05	0.00314	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—CYP19A1—osteoporosis	5.99e-05	0.0031	CbGpPWpGaD
Paramethadione—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	5.96e-05	0.00308	CbGpPWpGaD
Paramethadione—CYP2C8—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.93e-05	0.00307	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—IL6R—osteoporosis	5.88e-05	0.00304	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—IL6R—osteoporosis	5.7e-05	0.00295	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	5.43e-05	0.00281	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	5.36e-05	0.00277	CbGpPWpGaD
Paramethadione—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	5.3e-05	0.00274	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	5.29e-05	0.00273	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—CYP19A1—osteoporosis	5.25e-05	0.00271	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—CYP19A1—osteoporosis	5.17e-05	0.00268	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	5.15e-05	0.00266	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—IL6—osteoporosis	4.98e-05	0.00258	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	4.92e-05	0.00255	CbGpPWpGaD
Paramethadione—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.83e-05	0.0025	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	4.8e-05	0.00248	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—TGFB1—osteoporosis	4.72e-05	0.00244	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—TNF—osteoporosis	4.4e-05	0.00228	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	4.27e-05	0.00221	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	4.21e-05	0.00218	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	4.01e-05	0.00207	CbGpPWpGaD
Paramethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.93e-05	0.00203	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	3.9e-05	0.00202	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.83e-05	0.00198	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—IL6—osteoporosis	3.67e-05	0.0019	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—POMC—osteoporosis	3.65e-05	0.00189	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—IL6—osteoporosis	3.56e-05	0.00184	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—IL6—osteoporosis	3.55e-05	0.00184	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—TGFB1—osteoporosis	3.48e-05	0.0018	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—PKM—osteoporosis	3.44e-05	0.00178	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—FDPS—osteoporosis	3.44e-05	0.00178	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—TGFB1—osteoporosis	3.37e-05	0.00174	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—PGLS—osteoporosis	3.26e-05	0.00169	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—GPD2—osteoporosis	3.26e-05	0.00169	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.26e-05	0.00169	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—TNF—osteoporosis	3.25e-05	0.00168	CbGpPWpGaD
Paramethadione—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.19e-05	0.00165	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—POMC—osteoporosis	3.15e-05	0.00163	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—TNF—osteoporosis	3.14e-05	0.00163	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.12e-05	0.00161	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—PNP—osteoporosis	2.98e-05	0.00154	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—ATIC—osteoporosis	2.98e-05	0.00154	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—PKM—osteoporosis	2.97e-05	0.00154	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—FDPS—osteoporosis	2.97e-05	0.00154	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—GPD2—osteoporosis	2.82e-05	0.00146	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—PGLS—osteoporosis	2.82e-05	0.00146	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	2.82e-05	0.00146	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	2.78e-05	0.00144	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.65e-05	0.00137	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—IL6—osteoporosis	2.62e-05	0.00136	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—ATIC—osteoporosis	2.58e-05	0.00133	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—PNP—osteoporosis	2.58e-05	0.00133	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—POMC—osteoporosis	2.57e-05	0.00133	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—IL6—osteoporosis	2.54e-05	0.00131	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—OXCT1—osteoporosis	2.54e-05	0.00131	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—CA2—osteoporosis	2.54e-05	0.00131	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—MGLL—osteoporosis	2.47e-05	0.00128	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—PKM—osteoporosis	2.42e-05	0.00125	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—FDPS—osteoporosis	2.42e-05	0.00125	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—GPD2—osteoporosis	2.29e-05	0.00119	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—PGLS—osteoporosis	2.29e-05	0.00119	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—CA2—osteoporosis	2.19e-05	0.00113	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—OXCT1—osteoporosis	2.19e-05	0.00113	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—MGLL—osteoporosis	2.14e-05	0.0011	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—IDH2—osteoporosis	2.1e-05	0.00109	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—PNP—osteoporosis	2.1e-05	0.00108	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—ATIC—osteoporosis	2.1e-05	0.00108	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.01e-05	0.00104	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—CYP27A1—osteoporosis	1.98e-05	0.00102	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—ACP5—osteoporosis	1.92e-05	0.000994	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—IDH2—osteoporosis	1.82e-05	0.000939	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—TPI1—osteoporosis	1.79e-05	0.000924	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—CA2—osteoporosis	1.78e-05	0.000923	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—OXCT1—osteoporosis	1.78e-05	0.000923	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—MGLL—osteoporosis	1.74e-05	0.000899	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—CYP27A1—osteoporosis	1.71e-05	0.000883	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—POMC—osteoporosis	1.69e-05	0.000875	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—P4HB—osteoporosis	1.68e-05	0.000869	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—ACP5—osteoporosis	1.66e-05	0.000859	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—GAPDH—osteoporosis	1.65e-05	0.000853	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.64e-05	0.000848	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.64e-05	0.000848	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—RAP1A—osteoporosis	1.61e-05	0.00083	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—PKM—osteoporosis	1.6e-05	0.000825	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—FDPS—osteoporosis	1.6e-05	0.000825	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—TPI1—osteoporosis	1.54e-05	0.000799	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—PGLS—osteoporosis	1.51e-05	0.000782	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—GPD2—osteoporosis	1.51e-05	0.000782	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—IDH2—osteoporosis	1.48e-05	0.000764	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—P4HB—osteoporosis	1.45e-05	0.000751	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—GAPDH—osteoporosis	1.43e-05	0.000737	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.39e-05	0.000719	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—RAP1A—osteoporosis	1.39e-05	0.000718	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—PNP—osteoporosis	1.38e-05	0.000716	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—ATIC—osteoporosis	1.38e-05	0.000716	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—ACP5—osteoporosis	1.35e-05	0.000699	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.33e-05	0.00069	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—ENO1—osteoporosis	1.3e-05	0.000671	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—PSMA2—osteoporosis	1.28e-05	0.000662	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—PSMA5—osteoporosis	1.28e-05	0.000662	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—TPI1—osteoporosis	1.26e-05	0.00065	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.21e-05	0.000626	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—P4HB—osteoporosis	1.18e-05	0.000611	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—CA2—osteoporosis	1.18e-05	0.000608	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—OXCT1—osteoporosis	1.18e-05	0.000608	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—GAPDH—osteoporosis	1.16e-05	0.0006	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—MGLL—osteoporosis	1.15e-05	0.000593	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—RAP1A—osteoporosis	1.13e-05	0.000584	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—ENO1—osteoporosis	1.12e-05	0.00058	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—PSMA5—osteoporosis	1.11e-05	0.000572	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—PSMA2—osteoporosis	1.11e-05	0.000572	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—CYP19A1—osteoporosis	1.04e-05	0.000537	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.85e-06	0.000509	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—IDH2—osteoporosis	9.75e-06	0.000504	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—CYP27A1—osteoporosis	9.17e-06	0.000474	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—ENO1—osteoporosis	9.13e-06	0.000472	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—PSMA2—osteoporosis	9e-06	0.000465	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—PSMA5—osteoporosis	9e-06	0.000465	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—CYP19A1—osteoporosis	8.97e-06	0.000464	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—ACP5—osteoporosis	8.92e-06	0.000461	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—ADCY5—osteoporosis	8.48e-06	0.000438	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—GPX1—osteoporosis	8.45e-06	0.000437	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—TPI1—osteoporosis	8.29e-06	0.000429	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—MTHFR—osteoporosis	7.8e-06	0.000403	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—P4HB—osteoporosis	7.79e-06	0.000403	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—GAPDH—osteoporosis	7.65e-06	0.000396	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—RAP1A—osteoporosis	7.45e-06	0.000385	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—ADCY5—osteoporosis	7.33e-06	0.000379	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—GPX1—osteoporosis	7.3e-06	0.000378	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—CYP19A1—osteoporosis	7.3e-06	0.000378	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—MTHFR—osteoporosis	6.74e-06	0.000349	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—POMC—osteoporosis	6.24e-06	0.000323	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—ENO1—osteoporosis	6.02e-06	0.000311	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—ADCY5—osteoporosis	5.97e-06	0.000308	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—GPX1—osteoporosis	5.94e-06	0.000307	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—PSMA2—osteoporosis	5.93e-06	0.000307	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—PSMA5—osteoporosis	5.93e-06	0.000307	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—MTHFR—osteoporosis	5.49e-06	0.000284	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—POMC—osteoporosis	5.39e-06	0.000279	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—CYP19A1—osteoporosis	4.81e-06	0.000249	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—POMC—osteoporosis	4.39e-06	0.000227	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—ADCY5—osteoporosis	3.93e-06	0.000203	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—GPX1—osteoporosis	3.92e-06	0.000203	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—MTHFR—osteoporosis	3.62e-06	0.000187	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—POMC—osteoporosis	2.89e-06	0.00015	CbGpPWpGaD
